⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRAX News
Praxis Precision Medicines, Inc. Common Stock
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Vormatrigine Program Update
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
globenewswire.com
PRAX